GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,395,000 | +6.4% | 698,242 | +6.5% | 0.05% | +23.1% |
| Q1 2022 | $28,562,000 | +3.3% | 655,704 | +4.6% | 0.04% | +5.4% |
| Q4 2021 | $27,657,000 | +20.1% | 627,154 | +4.1% | 0.04% | +8.8% |
| Q3 2021 | $23,031,000 | +14.1% | 602,742 | +18.9% | 0.03% | +13.3% |
| Q2 2021 | $20,191,000 | -16.9% | 507,023 | -25.6% | 0.03% | -25.0% |
| Q1 2021 | $24,306,000 | +5.3% | 681,034 | +8.6% | 0.04% | -2.4% |
| Q4 2020 | $23,074,000 | -15.1% | 627,008 | -13.2% | 0.04% | -26.8% |
| Q3 2020 | $27,183,000 | +7.8% | 722,191 | +16.8% | 0.06% | -3.4% |
| Q2 2020 | $25,214,000 | -2.9% | 618,143 | -9.7% | 0.06% | -19.4% |
| Q1 2020 | $25,954,000 | -37.8% | 684,859 | -22.8% | 0.07% | -17.2% |
| Q4 2019 | $41,711,000 | +13.3% | 887,551 | +2.9% | 0.09% | -7.4% |
| Q3 2019 | $36,801,000 | +6.2% | 862,469 | -0.4% | 0.09% | +5.6% |
| Q2 2019 | $34,650,000 | +19.2% | 865,771 | +24.4% | 0.09% | +8.5% |
| Q1 2019 | $29,076,000 | -6.9% | 696,074 | -14.8% | 0.08% | -18.8% |
| Q4 2018 | $31,240,000 | -5.9% | 816,991 | -1.1% | 0.10% | +6.3% |
| Q3 2018 | $33,193,000 | -0.3% | 826,478 | -0.1% | 0.10% | -6.9% |
| Q2 2018 | $33,297,000 | +0.2% | 826,954 | -2.7% | 0.10% | -2.9% |
| Q1 2018 | $33,234,000 | +16.7% | 849,604 | +5.9% | 0.10% | +16.7% |
| Q4 2017 | $28,480,000 | -22.9% | 802,457 | -11.9% | 0.09% | -29.7% |
| Q3 2017 | $36,941,000 | -6.6% | 910,345 | -0.8% | 0.13% | -12.3% |
| Q2 2017 | $39,555,000 | -3.9% | 917,957 | -6.0% | 0.15% | -8.2% |
| Q1 2017 | $41,153,000 | +19.7% | 976,388 | +9.5% | 0.16% | +8.9% |
| Q4 2016 | $34,374,000 | -19.6% | 891,343 | -10.1% | 0.15% | -24.0% |
| Q3 2016 | $42,770,000 | +82.1% | 991,330 | +82.9% | 0.19% | +76.1% |
| Q2 2016 | $23,486,000 | +24.5% | 541,871 | +16.5% | 0.11% | +9.0% |
| Q1 2016 | $18,859,000 | +3.2% | 465,301 | +2.7% | 0.10% | +5.3% |
| Q4 2015 | $18,274,000 | -58.7% | 452,989 | -60.6% | 0.10% | -61.8% |
| Q3 2015 | $44,239,000 | -51.7% | 1,150,859 | -47.8% | 0.25% | +3.8% |
| Q2 2015 | $91,585,000 | +87.6% | 2,203,762 | +108.3% | 0.24% | -10.1% |
| Q1 2015 | $48,824,000 | +17.1% | 1,058,133 | +8.5% | 0.27% | +15.1% |
| Q4 2014 | $41,679,000 | -1.9% | 975,200 | +5.5% | 0.23% | -37.8% |
| Q3 2014 | $42,479,000 | +29.0% | 924,066 | +50.1% | 0.37% | +26.0% |
| Q2 2014 | $32,934,000 | +8.8% | 615,824 | +8.8% | 0.30% | +2.1% |
| Q1 2014 | $30,274,000 | – | 565,942 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |